Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P180032/S025

Cerene Cryotherapy Device (Model number FGS-7000); Exhaust Collection Bag (Model number FGS-8000); Exhaust Collection Ba

Channel Medsystems, Inc. · Decision date Nov 3, 2026

MEDTECHLEDGER EXPLANATIONP180032/S025

What did the FDA approve?

The FDA recorded an approval decision dated 2026-11-03 for PMA supplement P180032/S025, submitted by Channel Medsystems, Inc. The supplement is classified as a Real-Time Process review with a stated reason of Change Design/Components/Specifications/Material. The listed title covers the Cerene Cryotherapy Device (model FGS-7000) together with Exhaust Collection Bag components (model FGS-8000 and a further truncated entry).

The recorded statement limits the action to approval of minor design changes to the Exhaust Collection Bag. This is a supplement-level decision, not a new approval of the Cerene Cryotherapy Device as a whole. The source does not describe the specific design changes, their technical rationale, or any supporting data, and it does not state clinical implications; those details would reside in the supplement review documents, which were not provided.

The device category is thermal ablation, endometrial, with product code MNB and specialty Obstetrics/Gynecology. The source gives no information on labeling changes, postmarket requirements, or effective date beyond the recorded decision date.

FDA approval order statement

Approval for minor design changes to the Exhaust Collection Bag.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Obstetrics/Gynecology
Decision date
Nov 3, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P180032/S025
Regulatory pathway
PMA supplement
Product code
MNB
Decision code
APPR
Decision date
Nov 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, thermal ablation, endometrial.

Product code
MNB
FDA device class
3

For the original device and its historical approval scope, see PMA P180032. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P180032 · Original PMA

    Cerene Cryotherapy Device

  2. P180032/S024 · Related supplement

    Cerene Cryotherapy Device

  3. P180032/S025 received

    Application receipt date recorded by FDA.

  4. P180032/S025 · FDA decision

    Real-Time Process

Timeline entries are records held by MedtechLedger for P180032. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P180032

Product / regulatory recordCompanyPathwayDecision dateSource
Channel Medsystems, Inc.PMA approvalMar 28, 2019FDA
Channel Medsystems, Inc.PMA supplementSep 15, 2026FDA

Explore the linked device profile

Other records with product code MNB

Product / regulatory recordCompanyPathwayDecision dateSource
Axora Medical, Inc.PMA supplementNov 5, 2026FDA
Axora Medical, Inc.PMA approvalJul 27, 2015FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Channel Medsystems, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
5858 Horton St., Suite 200, Emeryville, CA, 94608

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records